Sensitive
point-of-care methods for detecting severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) antigens in clinical specimens
are urgently needed to achieve rapid screening of viral infection.
We developed a magnetic quantum dot-based dual-mode lateral flow immunoassay
(LFIA) biosensor for the high-sensitivity simultaneous detection of
SARS-CoV-2 spike (S) and nucleocapsid protein (NP) antigens, which
is beneficial for improving the detection accuracy and efficiency
of SARS-CoV-2 infection in the point-of-care testing area. A high-performance
magnetic quantum dot with a triple-QD shell (MagTQD) nanotag was first
fabricated and integrated into the LFIA system to provide superior
fluorescence signals, enrichment ability, and detectability for S/NP
antigen testing. Two detection modes were provided by the proposed
MagTQD-LFIA. The direct mode was used for rapid screening or urgent
detection of suspected samples within 10 min, and the enrichment mode
was used for the highly sensitive and quantitative analysis of SARS-CoV-2
antigens in biological samples without the interference of the “hook
effect.” The simultaneous detection of SARS-CoV-2 S/NP antigens
was conducted in one LFIA strip, and the detection limits for two
antigens under direct and enrichment modes were 1 and 0.5 pg/mL, respectively.
The MagTQD-LFIA showed high accuracy, specificity, and stability in
saliva and nasal swab samples and is an efficient tool with flexibility
to meet the testing requirements for SARS-CoV-2 antigens in various
situations.